Cardiovascular & General; Cardiovascular & Metabolic
Atrial Natriuretic Peptide (ANP)

For most of the twentieth century the heart was understood as a pump. In 1981 researchers injected an extract of rat atrial muscle into other rats and watched sodium pour out in the urine within minutes, and the heart became an endocrine organ as well. Atrial natriuretic peptide is the hormone behind that result, released by the upper chambers when they are stretched by too much fluid, carrying an instruction to the kidneys to shed salt and water. A manufactured version, carperitide, has been approved in Japan for acute heart failure since 1995 and nowhere else; a 2025 pooled analysis of roughly 2,400 patients found no difference against usual care in deaths or in heart failure hospitalisations.
Last updated
Mechanism
Binds natriuretic peptide receptor-A, a membrane guanylyl cyclase, raising cGMP to drive sodium excretion and vasodilation.
Reported effects
What sources associate with this compound. Reported categories, not outcomes we have graded — each would need its own citation and rung.
- Sodium excretion research
- Blood pressure context
- Heart failure biomarker
Dosing on file unverified
Infusion: 0.0125-0.1 µg/kg/min; 0.08-0.2 µg/kg/min; Bolus: 2 µg/kg/min; 0.015-0.075 µg/kg/min; 0.13 µg/kg/min
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
Half-life, storage & sport
- Elimination half-life
- 2–5 minutes (human, IV) — study. Journal of the Saudi Heart Association 2025.
The half-life on file is 4 min, measured intravenously. No dosing schedule could be read from this record, so the curve below is one dose drawn from the moment it is given. Nothing here says how often it is repeated.
The rise is not modelled and the axis is not a blood level. No absorption rate constant and no volume of distribution are on file, so each dose appears at full height the instant it is given, and the axis is percent of this compound's own peak.
Literature on file 3
-
animal in vivo
A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats (Life Sciences 1981, cited 2390x) graded on: an animal model — “rats”
-
review or editorial
Natriuretic Peptides (New England Journal of Medicine 1998, cited 1850x) graded on: indexed as "Review" - secondary literature, not a study — “Review”
Not graded
1 citation whose study design could not be read from the title. Left ungraded rather than guessed at.
-
not graded
NCT07617675: Perioperative Recombinant Human Brain Natriuretic Peptide for Renal Protection in Cardiac Surgery: the PROTECT-CS Randomized Clinical Trial graded on: NCT07617675 is not yet recruiting and has posted no results - a registration, not a reported outcome — “NCT07617675”
Identity
Skeletal formulathe canonical depiction
Drawn by PubChem from CID 16129708, the identifier on this record.
- Molecular weight
- 3080.5
- Molecular formula
- C127H203N45O39S3
- CAS number
- 89213-87-6
- PubChem CID
- 16129708
- UniProt
- P01160 (precursor)
- InChI key
- NSQLIUXCMFBZME-MPVJKSABSA-N
- SMILES
- CC[C@H](C)[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC4=CC=C(C=C4)O)C(=O)O)CC(C)C)CO)CCC(=O)N)C
- InChI
- InChI=1S/C127H203N45O39S3/c1-9-64(6)99-121(209)150-52-94(182)151-65(7)100(188)155-76(34-35-91(129)179)109(197)167-85(56-174)104(192)149-53-96(184)153-78(43-62(2)3)102(190)148-54-97(185)154-89(119(207)164-82(48-92(130)180)114(202)169-86(57-175)116(204)163-81(46-67-23-14-11-15-24-67)113(201)158-73(27-18-39-143-125(135)136)107(195)166-84(122(210)211)47-68-30-32-69(178)33-31-68)60-213-214-61-90(171-118(206)88(59-177)170-117(205)87(58-176)168-108(196)74(28-19-40-144-126(137)138)156-106(194)72(26-17-38-142-124(133)134)157-112(200)79(44-63(4)5)161-101(189)70(128)55-173)120(208)162-80(45-66-21-12-10-13-22-66)103(191)147-50-93(181)146-51-95(183)152-71(25-16-37-141-123(131)132)105(193)160-77(36-42-212-8)110(198)165-83(49-98(186)187)115(203)159-75(111(199)172-99)29-20-41-145-127(139)140/h10-15,21-24,30-33,62-65,70-90,99,173-178H,9,16-20,25-29,34-61,128H2,1-8H3,(H2,129,179)(H2,130,180)(H,146,181)(H,147,191)(H,148,190)(H,149,192)(H,150,209)(H,151,182)(H,152,183)(H,153,184)(H,154,185)(H,155,188)(H,156,194)(H,157,200)(H,158,201)(H,159,203)(H,160,193)(H,161,189)(H,162,208)(H,163,204)(H,164,207)(H,165,198)(H,166,195)(H,167,197)(H,168,196)(H,169,202)(H,170,205)(H,171,206)(H,172,199)(H,186,187)(H,210,211)(H4,131,132,141)(H4,133,134,142)(H4,135,136,143)(H4,137,138,144)(H4,139,140,145)/t64-,65-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,99-/m0/s1
Also called
- ANP (Atrial Natriuretic Peptide)
Caveat on these identifiers
NCT07617675 studies recombinant human BNP, not ANP.
Notes unverified prose
Multiple human studies; NCT07617675; Multiple human IV infusion studies
Not on file 1
1 of the 8 fields we track hold nothing on this record, and each says why. A blank field is a bug; a named absence is a finding.
- amino-acid sequencenothing we hold supplies it
Each field links to every other record missing the same thing. The full ledger holds 765 gaps across 163 records.